CDKN2A/B纯合性缺失与脑膜瘤的早期复发相关。 - Suppr

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas.

作者信息

Sievers Philipp, Hielscher Thomas, Schrimpf Daniel, Stichel Damian, Reuss David E, Berghoff Anna S, Neidert Marian C, Wirsching Hans-Georg, Mawrin Christian, Ketter Ralf, Paulus Werner, Reifenberger Guido, Lamszus Katrin, Westphal Manfred, Etminan Nima, Ratliff Miriam, Herold-Mende Christel, Pfister Stefan M, Jones David T W, Weller Michael, Harter Patrick N, Wick Wolfgang, Preusser Matthias, von Deimling Andreas, Sahm Felix

机构信息

Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

Clinical Cooperation Unit Neuropathology (B300), German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

出版信息

Acta Neuropathol. 2020 Sep;140(3):409-413. doi: 10.1007/s00401-020-02188-w. Epub 2020 Jul 8.

DOI:10.1007/s00401-020-02188-w

PMID:32642869

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7423850/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fd/7423850/5d5fc90f9c4f/401_2020_2188_Fig1_HTML.jpg

相似文献

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas.CDKN2A/B纯合性缺失与脑膜瘤的早期复发相关。

Acta Neuropathol. 2020 Sep;140(3):409-413. doi: 10.1007/s00401-020-02188-w. Epub 2020 Jul 8.

Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.p16表达缺失是恶性脑膜瘤中CDKN2A纯合缺失的敏感标志物。

Acta Neuropathol. 2023 Apr;145(4):497-500. doi: 10.1007/s00401-023-02544-6. Epub 2023 Feb 1.

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.CDKN2A 基因 mRNA 表达升高是临床侵袭性脑膜瘤的转录组学标志物。

Acta Neuropathol. 2023 Jul;146(1):145-162. doi: 10.1007/s00401-023-02571-3. Epub 2023 Apr 24.

p16 Immunohistochemistry as a Screening Tool for Homozygous CDKN2A Deletions in CNS Tumors.p16 免疫组织化学作为中枢神经系统肿瘤中 CDKN2A 纯合缺失的筛查工具。

Am J Surg Pathol. 2024 Jan 1;48(1):46-53. doi: 10.1097/PAS.0000000000002148. Epub 2023 Nov 10.

[Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors].[甲硫腺苷磷酸化酶和p16作为脑肿瘤中CDKN2A纯合缺失的替代诊断标志物]

Zhonghua Bing Li Xue Za Zhi. 2024 May 8;53(5):439-445. doi: 10.3760/cma.j.cn112151-20230815-00069.

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.非典型性和间变性脑膜瘤中肿瘤抑制基因CDKN2A（p16(INK4a)）、p14(ARF)、CDKN2B（p15(INK4b)）和CDKN2C（p18(INK4c)）的改变。

Am J Pathol. 2001 Aug;159(2):661-9. doi: 10.1016/S0002-9440(10)61737-3.

Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.中枢神经系统 WHO 分级 2 级和 3 级脑膜瘤中 MTAP 免疫组化与荧光原位杂交检测的 CDKN2A 状态的相关性及其与临床病理特征的关系：一项单中心队列研究。

J Neuropathol Exp Neurol. 2022 Jan 29;81(2):117-126. doi: 10.1093/jnen/nlab127.

Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.分析复发性和非复发性脑膜瘤中 CDKN2A 基因的改变。

J Neurooncol. 2019 Dec;145(3):449-459. doi: 10.1007/s11060-019-03333-6. Epub 2019 Nov 15.

Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma.即使CDKN2A/B杂合性缺失也会大大加速侵袭性脑膜瘤的复发。

Acta Neuropathol. 2023 Apr;145(4):501-503. doi: 10.1007/s00401-023-02543-7. Epub 2023 Feb 2.

CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data.CDKN2A/B 缺失与脑膜瘤进展密切相关：一项个体患者数据的荟萃分析。

Acta Neuropathol Commun. 2023 Nov 28;11(1):189. doi: 10.1186/s40478-023-01690-y.

引用本文的文献

Spatially Encoded Oncogenesis and Transcriptional Plasticity in Meningioma: Drivers of Therapeutic Resistance and Opportunities for Targeted Intervention.脑膜瘤中的空间编码肿瘤发生与转录可塑性：治疗耐药的驱动因素及靶向干预机会

Cancers (Basel). 2025 Aug 19;17(16):2694. doi: 10.3390/cancers17162694.

Targeting epigenetic modifications as an emerging immunotherapeutic strategy for cancers.将表观遗传修饰作为一种新兴的癌症免疫治疗策略。

Immunol Res. 2025 Aug 19;73(1):121. doi: 10.1007/s12026-025-09678-7.

The concept, intention, and evaluation of the term treatment-refractory meningioma.治疗难治性脑膜瘤这一术语的概念、意图及评估

J Neurooncol. 2025 Nov;175(2):599-610. doi: 10.1007/s11060-025-05154-2. Epub 2025 Aug 4.

EZH2 overexpression is associated with aggressive behavior and promotes cell proliferation in CNS WHO grade 3 meningiomas.EZH2过表达与侵袭性行为相关，并促进中枢神经系统WHO 3级脑膜瘤的细胞增殖。

Neurooncol Adv. 2025 Jun 5;7(1):vdaf112. doi: 10.1093/noajnl/vdaf112. eCollection 2025 Jan-Dec.

Pan-cancer copy number analysis identifies optimized size thresholds and co-occurrence models for individualized risk stratification.泛癌拷贝数分析确定了用于个体化风险分层的优化大小阈值和共现模型。

Nat Commun. 2025 Jul 2;16(1):6024. doi: 10.1038/s41467-025-61063-y.

Case Report: The price of intraoperative cell salvage? - implantation metastases of meningioma in both lungs and left cubital fossa.病例报告：术中血液回收的代价？——脑膜瘤肺及左肘窝种植转移

Front Oncol. 2025 May 28;15:1535048. doi: 10.3389/fonc.2025.1535048. eCollection 2025.

Radiation-Induced Meningiomas Have an Aggressive Clinical Course: Genetic Signature Is Limited to Alterations, and Epigenetic Signature Is H3K27me3 Loss.辐射诱导的脑膜瘤具有侵袭性临床病程：基因特征仅限于改变，表观遗传特征为H3K27me3缺失。

J Korean Med Sci. 2025 May 12;40(18):e62. doi: 10.3346/jkms.2025.40.e62.

Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival.MIB-1指数在脑膜瘤中的预后价值：一项回顾性队列研究以确定复发和生存的最佳临界值

J Neurooncol. 2025 May 12. doi: 10.1007/s11060-025-05057-2.

Comprehensive analysis of prognosis and tumor immune microenvironment of cuproptosis-related gene CDKN2A in lung adenocarcinoma.肺腺癌中铜死亡相关基因CDKN2A的预后及肿瘤免疫微环境综合分析

BMC Pulm Med. 2025 Apr 14;25(1):179. doi: 10.1186/s12890-025-03631-y.

Meningioma: Novel Diagnostic and Therapeutic Approaches.脑膜瘤：新型诊断与治疗方法

Biomedicines. 2025 Mar 7;13(3):659. doi: 10.3390/biomedicines13030659.

本文引用的文献

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.TERT 基因突变与脑膜瘤不良预后相关，与世界卫生组织分级无关：一项基于个体患者数据的荟萃分析。

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387. doi: 10.1136/jnnp-2019-322257. Epub 2020 Feb 10.

Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.分析复发性和非复发性脑膜瘤中 CDKN2A 基因的改变。

J Neurooncol. 2019 Dec;145(3):449-459. doi: 10.1007/s11060-019-03333-6. Epub 2019 Nov 15.

DNA methylation-based classification of central nervous system tumours.基于 DNA 甲基化的中枢神经系统肿瘤分类。

Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14.

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.基于 DNA 甲基化的脑膜瘤分类和分级系统：一项多中心回顾性分析。

Lancet Oncol. 2017 May;18(5):682-694. doi: 10.1016/S1470-2045(17)30155-9. Epub 2017 Mar 15.

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类：概述。

Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.

Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.在常规脑肿瘤诊断中进行下一代测序可实现综合诊断并确定可行的靶点。

Acta Neuropathol. 2016 Jun;131(6):903-10. doi: 10.1007/s00401-015-1519-8. Epub 2015 Dec 15.

TERT Promoter Mutations and Risk of Recurrence in Meningioma.端粒酶逆转录酶（TERT）启动子突变与脑膜瘤复发风险

J Natl Cancer Inst. 2015 Dec 13;108(5). doi: 10.1093/jnci/djv377. Print 2016 May.

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.TERT 启动子突变在儿童和成人神经系统肿瘤中的分布。

Acta Neuropathol. 2013 Dec;126(6):907-15. doi: 10.1007/s00401-013-1195-5. Epub 2013 Oct 24.

Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status.基因组分析揭示了依赖于潜在 NF2 状态的脑膜瘤恶性进展的替代遗传途径。

Clin Cancer Res. 2010 Aug 15;16(16):4155-64. doi: 10.1158/1078-0432.CCR-10-0891. Epub 2010 Aug 3.

New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology.基于14号染色体异常、患者年龄和肿瘤组织病理学的脑膜瘤预后分层新分类方案。

J Clin Oncol. 2003 Sep 1;21(17):3285-95. doi: 10.1200/JCO.2003.07.156.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献